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ABSTRACT  
Objective: Since the 1990s, pregnancy hypertension rates have declined in some countries but not 
all. Increasing rates of early planned delivery (before the due date) have been hypothesised as the 
reason for the decline. The aim of this study was to explore whether early planned delivery can 
partly explain the declining pregnancy hypertension rates in Australia. 
Design: Population-based record linkage study utilising linked birth and hospital records 
Setting and Participants: A cohort of 1,076,122 deliveries in New South Wales, Australia, 2001-
2012.  
Outcome measures: Pregnancy hypertension (including gestational hypertension, preeclampsia and 
eclampsia) was the main outcome, preeclampsia was a secondary outcome 
Results:  From 2001 to 2012, pregnancy hypertension rates declined by 22% from 9.9% to 7.7% 
and preeclampsia by 27% from 3.3% to 2.4% (trend P <0.0001). At the same time, planned 
deliveries increased: prelabour caesarean section by 43% (12.9% to 18.4%) and labour inductions 
by 10% (24.8% to 27.2%). Many maternal risk factors for pregnancy hypertension significantly 
increased (P<0.01) over the study period including nulliparity, age ≥35 years, diabetes, overweight 
and obesity, and use of assisted reproductive technologies; some risk factors decreased including 
multi-fetal pregnancies, age <20 years, autoimmune diseases and previous pregnancy hypertension. 
Given these changes in risk factors the pregnancy hypertension rate was predicted to increase to 
10.5%.  Examination of annual gestational age distributions showed that pregnancy hypertension 
rates actually declined from 38 weeks gestation and were steepest from 41 weeks; at least 36% of 
the decrease could be attributed to planned deliveries. The risk factors for pregnancy hypertension 
were also risk factors for planned delivery. 
Conclusions:  It appears that an unanticipated consequence of increasing early planned deliveries is 
a decline in the incidence of pregnancy hypertension. Women with risk factors for hypertension 
were relatively more likely to be selected for early delivery. 
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Strengths and limitations of this study 
• A strength of the study is the use of longitudinally linked, population-based data over a recent 
12 year period 
• Record linkage improves the ascertainment of pregnancy hypertension and covariates , which 
are known to be reliably reported 
• Population level data lack detailed clinical information including medications that reduce the 
risk of hypertensive diseases (e.g. aspirin, calcium supplementation, antihypertensives) and 
importantly the detailed reasons for obstetric interventions 
• Pregnancy hypertension can be an indication for planned delivery but early planned delivery 
may also mean pregnancy hypertension is avoided – and these relationships can be hard to 
untangle in routinely collected data. 
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INTRODUCTION 
Hypertensive disorders of pregnancy include both pregnancy-induced and pre-existing 
conditions.[1] For those that are pregnancy-induced, the cause remains elusive. However, a number 
of factors are known to be associated with increased and decreased risk of new onset of 
hypertension during pregnancy.  Nulliparity, extremes of maternal age, multiple births, diabetes, 
chronic hypertension, obesity, a hypertensive disorder in a previous pregnancy, renal disease, the 
presence of antiphospholipid antibodies, prolonged inter-pregnancy interval, assisted reproductive 
technologies, family history of preeclampsia and a new partner are all associated with increased risk 
of a woman having a hypertensive disorder.[2-11]  Factors associated with a reduced risk include 
smoking, Asian ethnicity, summer births, aspirin and calcium supplementation in high-risk women, 
treatment of gestational diabetes and use of anti-hypertensive medications.[12-18, 3, 19-21, 6, 11, 
10] At a population level changes in the frequency of these risk factors would be expected to 
influence the overall population rate. Some factors are known to be increasing in many populations 
(eg nulliparity, older maternal age, multiple births, diabetes, obesity and assisted reproductive 
technologies), while smoking among pregnant women is declining in high income countries.   
 
Since the 1990s, pregnancy hypertension (including gestational hypertension, preeclampsia and 
eclampsia) has declined in Australia, Scotland, Sweden and New York (USA), but not in Alberta 
(Canada), Denmark or Norway although preeclampsia declined in Norway and Denmark.[5, 22, 23] 
In contrast, both pregnancy hypertension and preeclampsia increased in the USA.[24, 23, 25]  As 
most (~75%) pregnancy hypertension occurs at term,[11] increasing rates of planned delivery 
before the due date means some women may birth before they develop pregnancy hypertension.  A 
marked downward shift in gestational age towards births at earlier term gestations since the 1990s 
has been attributed to increasing rates of planned births with fewer births commencing 
spontaneously.[26-30]  This was hypothesised as an explanation for the declining rates of 
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pregnancy hypertension in countries that reported declines.[23]  Temporal changes in the 
management of women with established pregnancy hypertension, would not affect the reported 
incidence rates of de novo hypertension. 
 
Therefore, the aim of this study was to explore whether early planned delivery can partly explain 
the declining pregnancy hypertension rates in Australia. Planned early delivery may be non-
selective with respect to hypertension risk (eg elective repeat caesarean section) or selective 
(women with prior pregnancy hypertension, obesity, advanced maternal age or other risk factors for 
hypertension may be relatively more likely to be scheduled for early delivery). If planned early 
delivery is selective there should be a marked drop in rates of pregnancy hypertension at ≥40 weeks 
as women most at risk are delivered early while lower risk women are allowed to continue. 
Alternatively, if the decline in pregnancy hypertension rate is unrelated to the timing of birth, then 
any decline in gestation-specific rates should be uniform.  
 
METHODS 
Study population and data sources 
The study population was derived from all women who gave birth in New South Wales, Australia 
2001-2012.  NSW is the most populous state of Australia (~7 million people) and almost one-third 
of all Australian births occur in NSW.  Australia has a national health system and maternity care is 
available free of charge to all women in public hospitals. However about one-third of women 
choose private maternity care (through health insurance or payment).   
 
Data for the study were obtained from two linked population health datasets: the New South Wales 
(NSW) Perinatal Data Collection (PDC, referred to as birth records) and the NSW Admitted Patient 
Data Collection (APDC, referred to as hospital records).  The PDC is a statutory surveillance 
6 
 
system of all births in NSW of at least 20 weeks gestation or at least 400 grams birth weight.  
Information on maternal characteristics, pregnancy, labour, delivery, and infant outcomes are 
recorded by the attending midwife or doctor.  The APDC is a census of all NSW inpatient hospital 
discharges from both public and private hospitals, and day procedure units, and includes 
demographic and episode-related data; diagnoses and procedures are coded for each admission from 
the medical records according to the 10th revision of the International Statistical Classification of 
Diseases and Related Health Problems, Australian Modification (ICD-10-AM) and the affiliated 
Australian Classification of Health Interventions.[31] 
 
Longitudinal linkage of hospital records was available (from July 2000 to December 2012) and of 
birth records from 1994.  As Australia does not have a unique registration number for citizens, the 
separate datasets were linked using probabilistic linkage and a best practice approach in preserving 
privacy.[32, 33] This involves a process of blocking and matching combinations of selected 
variables such as name, date of birth, address and hospital and assigning a probability weight to the 
match.[34]  Record linkage was undertaken by the NSW Centre for Health Record Linkage 
(CHeReL).[32]  The validity of probabilistic record linkage is high;[35] and the linkage proportion 
for maternal hospital and birth records is 98.1%.[34] The researchers were provided with 
anonymised data. Ethics approval for the study was obtained from the NSW Population and Health 
Services Research Ethics Committee (2002/12/430). 
 
Outcomes 
The primary outcome was pregnancy hypertension at the time of delivery which was obtained if 
recorded in either the birth record (check-box) or a hospital record (physician recorded diagnosis 
coded according to the ICD10-AM) at any time during pregnancy.[36-38] Identification in this 
manner (using more than one data source) has been demonstrated to be accurate and reliable when 
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compared with medical records (e.g. sensitivity 82%, positive predictive value [PPV] 92% in 
NSW).[38] Preeclampsia was a secondary outcome because reporting in population data is less 
accurate (e.g. sensitivity 71%, PPV 67% in NSW) due to misclassification between gestational 
hypertension and preeclampsia.[39, 38, 40] 
 
During the study period, gestational hypertension was defined as de novo onset of hypertension 
(systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg) from 20 weeks’ 
gestation onwards and preeclampsia as the de novo onset of hypertension from 20 weeks’ gestation 
onwards with one or more of proteinuria, renal insufficiency, liver involvement, neurological 
complications, haematological complications or fetal growth restriction.[41, 1] 
 
Explanatory factors 
The factor of primary interest was planned birth by either induction of labour or prelabour 
caesarean section, especially planned births at 37-39 weeks. Hypertension can be identified as the 
reason for labour induction (one of 10 tick-boxes) but the reasons for caesarean section are limited 
to failure to progress, fetal distress and ‘other’ indications. 
 
Information on established risk factors for pregnancy hypertension and preeclampsia that was 
available for analysis included: maternal age at delivery (<20, 20-34, ≥35 years), nulliparity, Asian 
ethnicity (based on country of birth), multi-fetal pregnancy, smoking during pregnancy, summer 
birth and inter-pregnancy interval ≥5 years (with lookback to 1994). Information on maternal 
medical conditions and reproductive history was obtained from for non-pregnancy and pregnancy-
related hospital admissions from 2000, including chronic hypertension, diabetes (pregestational or 
gestational), morbid obesity, previous pregnancy hypertension, renal disease, autoimmune diseases 
(including rheumatoid arthritis, systemic lupus erythematosis and other rare autoimmune diseases) 
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and use of assisted reproductive technology (ART). We also obtained annual area level 
overweight/obesity prevalence rates (body mass index ≥25 kg/m2) for women by age (15-24, 25-34, 
≥35 years) from the NSW Adult Population Health survey.[42]  Few records were missing data on 
these factors (<0.4%). The explanatory factors are reported with a high level of accuracy.[43, 36, 
44, 45, 38, 46] 
 
Statistical Analysis  
Descriptive statistics were used to summarise the distribution and trends in pregnancy hypertension 
and preeclampsia, and maternal risk factors and pregnancy characteristics. We determined the 
trends in pregnancy hypertension rates among women with established risk factors. To assess the 
role of maternal risk factors in selection for early delivery, we calculated the relative risk (RR) and 
95% confidence interval (95% CI) for early planned delivery by each maternal risk factor among 
women without pregnancy hypertension. Trends were assessed using the χ2 for trend statistic and 
the P-value was set at <0.01 because of the large number of both statistical tests and records. 
 
To determine whether changes in maternal risk factors in the population could account for the 
observed pregnancy hypertension trend, we used predictive modelling to project the expected trend 
in pregnancy hypertension.  Using methods previously described [47] and all births in 2001-2002, 
two multivariable logistic regression predictive models for pregnancy hypertension were 
developed. The first included all available recognised risk factors for pregnancy hypertension and 
the second additionally included an indicator of planned birth other than for hypertension. Data 
from subsequent years were applied to the regression equation to account for the actual changes in 
maternal factors over time and produce a predicted trend for 2001-2012. Deliveries which had 
missing data (0.9%) on one or more risk factor were excluded from this analysis. Any difference in 
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the two predicted trends would suggest that planned births explained some of the predicted 
increase. 
 
To specifically assess the impact of changes over time in gestational age at birth, annual gestational 
age distributions were determined (proportion of all deliveries occurring in a specific gestational 
week per total deliveries which took place that year) and plotted. These distributions are presented 
separately for women with and without pregnancy hypertension, and by labour onset (spontaneous, 
labour inductions and prelabour caesarean section). We also plotted gestation-specific trends in 
pregnancy hypertension using a pregnancy-at-risk approach (ie the denominator was women still 
pregnant at the beginning of each gestational week).[48] 
 
Finally, a priori, all analyses were repeated for nulliparous women with singleton pregnancies but as 
the patterns for the most part were the same as for all women these results are not presented. 
 
RESULTS 
From 2001 through 2012, there were 1,076,122 deliveries in NSW. The observed pregnancy 
hypertension rates declined by 22% from 9.9% to 7.7% Preeclampsia declined by 27% from 3.3% 
in 2001 to 2.4% in 2012. Similar declines were observed among nulliparous women with singleton 
pregnancies, 13.5% to 10.1% and 5.0% to 3.5% respectively. All trend P-values were <0.0001. 
 
During the study period, changes in the maternal risk factors for pregnancy hypertension were 
mostly in a direction that would likely increase the rate of pregnancy hypertension including 
increases in nulliparous women, maternal age ≥35 years, maternal diabetes, overweight and obesity, 
use of ART; and a decline in smoking during pregnancy (Table 1).  
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Table 1: Trends in maternal hypertension risk factors, obstetric factors and sociodemographic 
characteristics, NSW 2001-2012 
Risk factor  Risk factor prevalence 
2001 
N=84,302 
n (%) 
2012 
N=96,051 
n (%) 
Trend over time 
P-value 
Established risk factors for 
pregnancy hypertension 
   
Nulliparity 35,134 (41.7) 42,189 (43.9) <0.0001 
Maternal age ≥35 yrs 15,222 (18.1) 22,556 (23.5) <0.0001 
Maternal age <20 yrs 3,797 (  4.5) 3,158 (  3.3) <0.0001 
Diabetes  4000 (  4.7) 8,812 (  9.2) <0.0001 
Morbid obesity 125 (  0.2) 809 (  0.8) <0.0001 
NSW Overweight/obesity rate  
   Overweight 
   Obese 
28.4% 
17.6% 
10.8% 
33.2% 
19.7% 
13.5% 
 
Not reported 
ART 1323 (  1.6) 2,971 (  3.1) <0.0001 
Smoking  15,629 (18.5) 11,046 (11.5) <0.0001 
Multiple births 1,452 (  1.7) 1,316 (  1.4) <0.0001 
Autoimmune diseases  387 (  0.5) 404 (  0.4) <0.0001 
Previous pregnancy hypertension* 3,932 (  8.0) † 3,929 (  7.3) <0.0001 
Asian ethnicity 7,924 (  9.4) 17,647 (18.4) <0.0001 
Chronic hypertension 548 (  0.7) 622 (  0.7) 0.12 
Renal disease  186 (  0.2) 278 (  0.3) 0.24 
Inter-pregnancy interval ≥5 yrs* 7,156 (15.9) † 7,461 (15.6) 0.62 
Summer birth  20,143 (23.9) 23, 193 (24.2) 0.27 
    
Obstetric factors    
Gestational age     
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   <37 
   37 
   38 
   39 
   40 
   ≥41 
5,457 (  6.5) 
4,215 (  5.0) 
12,491 (14.8) 
18,993 (22.5) 
26,780 (31.8) 
16,354 (19.4) 
6,649 (  6.9) 
6,544 (  6.8) 
17,654 (18.4) 
28,395 (29.6) 
24,183 (25.2) 
12,622 (13.1) 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
Planned deliveries (any) 
   Pelabour CS 
   Labour inductions 
Any planned delivery at 37-39 weeks 
31,823 (37.8) 
10,910 (12.9) 
20,913 (24.8) 
15,007 (17.8) 
43,846 (45.7) 
17,705 (18.4) 
26,141 (27.2) 
26,058 (27.1) 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
    
Socio-demographic factors    
Socio-economic status 
   Lowest (quintile) 
   Middle (quintiles 2-4) 
   Highest (quintile) 
 
16,903 (20.1) 
51,277 (60.8) 
16,007 (19.0) 
 
18,911 (19.7) 
57,231 (59.6) 
19,126 (19.9) 
 
0.15 
<0.0001 
<0.0001 
Maternal residence (urban vs rural) 57,537 (68.3) 68,290 (71.5) <0.0001 
Maternity hospital type 
   Tertiary obstetric 
   Urban district 
   Rural district 
   Private 
 
36,415 (43.2) 
19,333 (22.9) 
9,237 (11.0) 
19, 317 (22.9) 
 
47,020 (49.0) 
18,824 (19.6) 
8,412 (  8.8) 
21,795 (22.7) 
 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
Percents may not add to 100% because of missing data 
* among multipara 
† reported rate is for 2003 (prior pregnancy hypertension) and 2006 (inter-pregnancy interval) allow a sufficient 
lookback period for previous pregnancies 
 
In contrast changes in factors that would be consistent with a decrease in pregnancy hypertension 
rates included a significant decline in multi-fetal pregnancies, young maternal age, pregnancies 
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complicated by maternal autoimmune diseases, previous pregnancy hypertension among 
multiparous women; and an increase in Asian-born women. There was no significant change in the 
prevalence of chronic hypertension, renal disease, prolonged pregnancy interval or summer births. 
 
Planned deliveries increased overall by 21% from 37.8% of all deliveries in 2001 to 45.7% in 2012 
and at 37-39 weeks by 52% from 17.8% to 27.1% (Table 1). Increases occurred in both labour 
inductions and prelabour caesarean sections. Among the labour inductions, the proportion where 
hypertension was recorded as the reason for induction declined from 13.6% to 9.4%. Among 
women undergoing a prelabour caesarean section the incidence of pregnancy hypertension also 
declined from 13.7% to 10.3%.  
 
Among women with risk factors for pregnancy hypertension, the rate of pregnancy hypertension 
declined significantly over time (P for trend <0.001) with the exception of chronic hypertension, 
maternal age <20 years and preterm births (Table 2).  
 
Table 2: Trend in pregnancy hypertension rates among women with maternal and obstetric risk 
factors, 2001 and 2012 
Risk factor  Pregnancy hypertension rates  
Rate 
difference† 
 
Rate ratio 
(95% CI) † 
 
2001 
n (row %) 
 
2012 
n (row %) 
Trend over 
time 
P-value 
All women 8,356 (  9.9) 7,433 (  7.7) <0.0001 -2.2 0.78 (0.76-0.80) 
Maternal risk factors      
Nulliparity 4,827 (13.7) 4,362 (10.3) <0.0001 -3.4 0.75 (0.72-0.78) 
Maternal age ≥35 yrs 1,524 (10.0) 1,907 (  8.5) <0.0001 -1.6 0.84 (0.79-0.90) 
Maternal age <20 yrs 394 (10.4) 304 (  9.6) 0.18 -0.8 0.93 (0.80-1.07) 
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Diabetes  623 (15.6) 1,058 (12.0) <0.0001 -3.6 0.77 (0.70-0.84) 
Morbid obesity 56 (45.2) 196 (24.2) <0.0001 -20.9 0.54 (0.43-0.68) 
ART 200 (15.1) 283 (  9.5) <0.0001 -5.6 0.63 (0.53-0.75) 
Smoking  1,183 (  7.6) 763 (  6.9) <0.0001 -0.7 0.91 (0.83-0.99) 
Multiple births 292 (20.1) 226 (17.2) 0.0013 -2.9 0.85 (0.73-1.00) 
Autoimmune diseases  67 (16.5) 53 (13.1) 0.007 -3.4 0.79 (0.57-1.11) 
Previous pregnancy hypertension* 1144 (36.3) 1249 (31.8) 0.0001 -4.5 0.88 (0.82-0.94) 
Asian ethnicity 558 (  7.0) 935 (  5.3) <0.0001 -1.6 0.75 (0.68-0.83) 
Chronic hypertension 132 (24.1) 160 (25.7) 0.48 1.6 1.07 (0.87-1.30) 
Renal disease  49 (26.5) 52 (18.7) 0.009 -7.8 0.71 (0.50-1.00) 
Summer birth  1,800 (  8.9) 1,722 (  7.4) <0.0001 -1.5 0.83 (0.78-0.89) 
      
Obstetric factors      
Gestational age  
   <37 
   37 
   38 
   39 
   40 
   ≥41 
 
1,005 (18.4) 
716 (17.0) 
1,562 (12.5) 
1,805 (  9.5) 
2,218 (  8.3) 
1,047 (  6.4) 
 
1,203 (18.1) 
929 (14.2) 
1,524 (  8.6) 
1,788 (  6.3) 
1,404 (  5.8) 
584 (  4.6) 
 
0.35 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
 
-0.3 
-2.8 
-3.9 
-3.2 
-2.5 
-1.8 
 
0.98 (0.89-1.07) 
0.84 (0.76-0.91) 
0.69 (0.65-0.74) 
0.66 (0.62-0.71) 
0.70 (0.66-0.75) 
0.72 (0.65-0.80) 
Planned deliveries (any) 
   Prelabour CS 
   Labour inductions 
Planned delivery at 37-39 weeks 
5,719 (18.0) 
1,484 (13.6) 
4,235 (20.3) 
2,932 (19.5) 
5,604 (12.8) 
1,819 (10.3) 
3,785 (14.5) 
3,281 (12.6) 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
-5.2 
-3.3 
-5.8 
-7.0 
0.71 (0.69-0.74) 
0.76 (0.71-0.81) 
0.72 (0.69-0.74) 
0.64 (0.62-0.67) 
 
* among multipara  
† Among women with the specified risk factor in 2012 compared with 2001 
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The relative decrease (rate ratio) in pregnancy hypertension rates was greatest among morbidly 
obese women and least (but still statistically significant) among smokers. Compared to the overall 
decline (by 22%, rate ratio 0.78), the decline in pregnancy hypertension was greater among planned 
births at 37-39 weeks (by 36%, rate ratio 0.64) and for all gestations from 38 weeks (by ≥28.0%, 
rate ratios ≤0.72). 
 
Among women who never developed pregnancy hypertension, many of the established risk factors 
for hypertension were also positively associated with planned births at 37-39 weeks including 
maternal ≥35 years (RR=1.58, 95%CI 1.56-1.59), multiple pregnancy (RR=1.76, 95%CI 1.71-1.81), 
diabetes (RR=2.07, 95%CI 2.04-2.10), chronic hypertension (RR=1.95, 95%CI 1.87-2.03), morbid 
obesity (RR=1.94, 95%CI 1.83-2.06), renal disease (RR=1.21, 95%CI 1.12-1.32), autoimmune 
diseases (RR=1.81, 95%CI 1.72-1.91), use of assisted reproductive technology (RR=1.63, 95%CI 
1.60-1.67), and pregnancy hypertension in a previous pregnancy (RR=1.62, 95%CI 1.59-1.65). 
Nulliparity, young maternal age, smoking and Asian ethnicity were negatively associated with 
planned birth among women without pregnancy hypertension. 
 
Based on changes in the risk profile of the maternity population, the pregnancy hypertension rate 
was predicted to increase to 10.5% (Figure 1). When planned birth was included in the predictive 
model, the pregnancy hypertension trend was forecast to decrease to 9.5%. The difference in two 
predicted rates (1.0%) suggests planned births explained at least 36% of difference between the 
observed and predicted rates (based on maternal risk factors alone). 
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Figure 1: Observed and predicted trends in pregnancy hypertension, NSW 2001-2012 
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From 2001 through 2012, there was a marked difference in the distribution of gestational age for 
women with and without pregnancy hypertension at delivery (Figure 2). For women without 
pregnancy hypertension, the gestational age distribution curves shift to the left from 2001 through 
2012 with a substantial increase in the percentage of births occurring at 39 weeks (Figure 2A). In 
contrast, for women with pregnancy hypertension (Figure 2B), there was a decline in the percentage 
of births from 38 weeks onwards but most notably ≥40 weeks. Births at these latter gestations 
disappear from the distribution in the later years of the study period, thereby changing the shape of 
the distribution. This is also demonstrated by the statistically significant declines in gestation-
specific trends in pregnancy hypertension rates at delivery among pregnancies at risk from 38 
weeks with the steepest declines at the later gestations (Supplementary Figure). Planned deliveries 
drove these changes in the gestational age distribution as can be seen by the gestational age 
distribution in the labour onset groups (Figure 3). Since 2001, both inductions and prelabour 
caesarean sections have increased from 36 – 39 weeks with fewer women reaching 40 weeks and 
going into spontaneous labour. These patterns were also observed for preeclampsia and among 
nulliparae with a singleton pregnancy. 
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Figure 2: Annual distribution of gestational age 2001-2012 for women A) without pregnancy 
hypertension at delivery and B) with pregnancy hypertension at delivery 
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Figure 3: Distribution of gestational age among all deliveries 2001-2012, by year and labour onset. 
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DISCUSSION 
Principal findings  
Continuing from the trend observed in the 1990s,[23] the rates of pregnancy hypertension and 
preeclampsia have continued to decline in this Australian population.  On balance the trends in 
maternal risk factors for pregnancy hypertension and predictive modelling suggest that pregnancy 
hypertension and preeclampsia should have increased over the 12 years and that early planned 
deliveries explain some of the decline. Of note, there was no change in preterm pregnancy 
hypertension rates. Rates start to decline among pregnancies that reached 38 weeks gestation, with 
the steepest declines at the latest gestations.  While it is hard to conclusively demonstrate that 
hypertension has been prevented, our findings support the hypothesis that a consequence of 
increasing rates of planned early delivery is a reduction in the number of women who develop a 
hypertensive disorder of pregnancy.  Furthermore the gestation specific trends are consistent with 
our hypothesis that women with risk factors for hypertension may be relatively more likely to be 
selected for early delivery. These findings are likely to be generalisable to other high income 
countries with contemporaneous increases in earlier elective deliveries, although other 
contemporaneous changes could offset the trend. 
 
Strengths and weaknesses of the study  
Our study utilises large, reliably collected linked population health data. [43, 36, 44, 45, 38, 46]  
International studies consistently demonstrate that pregnancy hypertension at the time of delivery 
are reliably and accurately reported in population health data.[39, 37, 38, 40, 49] Furthermore, 
ascertainment is improved by accessing data from more than one data source and by longitudinal 
record linkage.[36, 37, 7] Use of broad diagnosis categories in administrative data has been 
demonstrated to overcome the under-ascertainment and misclassification that can occur with more 
specific diagnoses.[43, 37, 38, 50]  However, population level data lack detailed clinical 
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information on the reasons for obstetric interventions and on some factors that are known to 
increase (family history of preeclampsia, a new partner), or decrease (low-dose aspirin and calcium 
supplementation in high-risk women, treatment of gestational diabetes and use of anti-hypertensive 
medications) the risk of the hypertensive disorders of pregnancy.  Investigation of the association 
between early planned delivery and a diagnosis of pregnancy hypertension is not well suited to the 
non-experimental methods, due to confounding by indication.[51]  Pregnancy hypertension, or the 
potential for it, can be the cause of an early planned delivery, as well as being an outcome which 
could be averted by early planned delivery. The limited degree of information on indications for 
planned delivery (which may be multifactorial) necessitated examining the association in multiple 
ways, to confirm that the results were mutually consistent.  In the absence of randomised controlled 
trials to specifically address this question, the contemporaneous changes provide circumstantial 
evidence of the impact of planned deliveries. 
 
Interpretation 
Several factors support a hypothesis of selective planned delivery for women at increased risk of 
pregnancy hypertension. First, the gestation-specific trends show the most marked decline in rates 
of pregnancy hypertension occur at from 40 weeks (Figure 2, Supplementary Figure). Second, we 
show strong associations between the established risk factors and early planned birth in the absence 
of hypertension. Third, the pregnancy hypertension rates declined significantly among nearly all the 
hypertension risk factors but also among planned births and especially among planned birth at 37-
39 weeks. Finally, including an indicator of planned birth in the predictive modelling suggests that 
planned births explain at least 36% of the decline in pregnancy hypertension. However, this is likely 
an underestimate because of the difficulty of accounting for indication.  
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A definitive answer to whether early planned birth prevents pregnancy hypertension would be 
obtained from a randomised trial.  While no such trial exists, we reviewed 39 intervention trials of 
immediate delivery versus expectant management for specific conditions (eg suspected growth 
restriction, macrosomia, prelabour rupture of the membranes, prolonged pregnancy, high risk 
pregnancies, diabetes).[52-58] Only one trial (among pregnancies with suspected growth restriction) 
reports pregnancy hypertension as an outcome, finding a significant reduction in progression to 
preeclampsia in the induction group.[52] Of note, implementation of findings of the HYPITAT trial 
(2009),[59] which showed that induction of labour for women with mild hypertensive disease at 
term improved maternal outcomes, should result in a decrease in the severity of the hypertensive 
disorders but not the overall incidence.  
 
Changes to reporting of, or diagnostic criteria for, pregnancy hypertension are potential alternate 
explanations for declining pregnancy hypertension rates.  In 2008, Australian guidelines changed to 
include non-proteinuric hypertension with multi-organ disease in the clinical diagnosis of 
preeclampsia.[60] However this would not change the rate of the broad category of pregnancy 
hypertension and supports the use of this outcome over the study period.  Data collection and 
coding has remained unchanged and the ascertainment of pregnancy hypertension from the 
administrative data sets was consistent over the study period. 
 
In conclusion, planned deliveries increased dramatically over the study period so that by 2012 
almost half (46%) of all women birthing in NSW had a planned delivery. Women with risk factors 
for de novo hypertension during pregnancy are increasingly likely to have a planned delivery. It 
appears that an unanticipated consequence of increasing rates of early planned delivery is a decline 
in the incidence of pregnancy hypertension.  Reducing the length of gestation by even a few days 
means that a substantial number of women deliver before they become hypertensive. 
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Supplementary Figure: Gestation specific rates of pregnancy hypertension at delivery among 
pregnancies-at-risk, 2001-2012 
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